City
Epaper

India gets largest PE investment in healthcare sector in Asia-Pacific region during 2024: Report

By ANI | Updated: April 23, 2025 11:42 IST

New Delhi [India], April 23 : With 26 per cent of the deal volume, India has emerged as the ...

Open in App

New Delhi [India], April 23 : With 26 per cent of the deal volume, India has emerged as the largest private equity buyout in the healthcare sector in the Asia-Pacific region in 2024, said a report by the global private investment firm Bain and Capital.

The wider Asia-Pacific market, however, grapples with a decline in buyout activity, with regional volumes plummeting by nearly 49 per cent.

"India also appears more resilient to deal downturns than other countries in the region, with buyout volumes dipping only 18 per cent from 2023, vs. a nearly 49 percent drop across Asia-Pacific overall", said the report

This growth can be attributed to a combination of buoyant capital markets, strong economic fundamentals, and a burgeoning investor confidence, fuelled by successful private equity exits, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma.

"Successful PE exits with strong returns, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma, have also validated India's buyout market, making it more attractive for future investment," the report added.

Strong growth is projected to continue in India's healthcare sector, with healthcare spending expected to reach USD 320 billion by 2028.

In India, over the past two years, investments have come in the provider and related services space and biopharma and related services, with a sharper focus on provider deals. In the provider space, investments have gravitated to hospitals, clinics, and supporting services.

The report highlighted that the India has consistently delivered favourable returns and has enabled a range of successful exits for PE firms through initial public offerings (boosted by strong public markets), strategic acquisitions (bolstered by acquirers' strong balance sheets), and sponsor-to-sponsor deals (such as KKR's USD 839 million acquisition of Healthium Medtech from Apax Funds).

"With a proven track record, favourable macroeconomic conditions, and a diverse healthcare landscape, India is expected to remain a prime investment location for PE firms," the report added.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

CricketRuturaj Gaikwad admits CSK lack 'X-factor' in bowling, hails team effort after win over DC

InternationalUS Navy starts mine-clearance operations in Strait of Hormuz

Other SportsPV Sindhu, Harmanpreet Kaur experience HYROX race in Bengaluru

InternationalEAM Jaishankar meets UAE Foreign Minister in Abu Dhabi; discusses West Asia security and strategic partnership

CricketSanju Samson credits CSK trust, resilience after match-winning century against DC in IPL 2026 clash

Business Realted Stories

BusinessIndia's marine product exports reach Rs 62,408 crore in 2024-25, exporters urged to work towards Rs 1 lakh crore target

BusinessDelhi BJP chief Virendra Sachdeva welcomes draft EV policy

BusinessIndia turns crisis into opportunity by augmenting strategic petroleum reserve capacities, diversifying imports

BusinessAIDA urges Centre to roll out ethanol-based cooking nationwide to cut reliance on imported LPG

BusinessGovt raises diesel duties, hikes ATF levy with immediate effect